In July 2020, five months after the product launch, Dupuy (et al.) published the first peer-reviewed publication on Procalcitonin FS in the MDPI (Multidisciplinary Digital Publishing Institute) journal Diagnostics (Vol. 10, Issue 7). The study compared the performance of DiaSys' new procalcitonin assay with BRAHMS PCT Kryptor© and another turbidimetric assay. DiaSys Procalcitonin FS demonstrated its strengths in the study and can truly be accepted as a reliable alternative for clinical use.
Exhibitor Data Sheet